BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16024007)

  • 1. Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function.
    Sotiriadou NN; Perez SA; Gritzapis AD; Mahaira LG; Salagianni M; Baxevanis CN; Papamichail M
    Cell Immunol; 2005 Mar; 234(1):67-75. PubMed ID: 16024007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukins 2 and 12 produce significant recovery of cytotoxic function in dibutyltin-exposed human natural killer cells.
    Whalen MM; Walker L; Loganathan BG
    Environ Res; 2002 Feb; 88(2):103-15. PubMed ID: 11908935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy.
    Zhang J; Sun R; Wei H; Zhang J; Tian Z
    Haematologica; 2004 Mar; 89(3):338-47. PubMed ID: 15020274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.
    Jewett A; Cacalano NA; Head C; Teruel A
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1994-2003. PubMed ID: 16609008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of various combinations of IL2, IL12 and IL15 on function of human peripheral blood derived NK cells].
    Li XH; Ma J; Wu XX; Li M; Wang FF; DA WM; Yu L; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):918-23. PubMed ID: 19698229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
    Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
    Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56(dim) natural killer cells.
    Zheng X; Wang Y; Wei H; Ling B; Sun R; Tian Z
    Mol Immunol; 2008 May; 45(9):2559-69. PubMed ID: 18295891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells.
    Sechler JM; Barlic J; Grivel JC; Murphy PM
    Cell Immunol; 2004 Aug; 230(2):99-108. PubMed ID: 15598425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
    Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity.
    Varchetta S; Oliviero B; Mavilio D; Mondelli MU
    Cytokine; 2013 Apr; 62(1):58-63. PubMed ID: 23490421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.